Amanote Research
Register
Sign In
Letter: Using a Placebo as a Comparator to Rifaximin for the Primary Prophylaxis of Spontaneous Bacterial Peritonitis-Is There Really an Ethical Concern?
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.14544
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
March 7, 2018
Authors
T. Thévenot
Publisher
Wiley
Related search
Systematic Review With Meta-Analysis: Rifaximin for the Prophylaxis of Spontaneous Bacterial Peritonitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Rifaximin-A Kick in the Gut for Spontaneous Bacterial Peritonitis? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
The Efficacy and the Immunomodulatory Effect of Rifaximin in Prophylaxis of Spontaneous Bacterial Peritonitis in Cirrhotic Egyptian Patients
Turkish Journal of Gastroenterology
Gastroenterology
Comparison of Efficacy of Rifaximin and Norfloxacin in Prevention of Spontaneous Bacterial Peritonitis
Annals of International medical and Dental Research
Spontaneous Bacterial Peritonitis;
The Professional Medical Journal
Is Spontaneous Bacterial Peritonitis Still Responding to Third Generation Cephalosporins? : A Single Centre Experience
International Journal of Current Microbiology and Applied Sciences
Spontaneous Bacterial Peritonitis Due to Campylobacter Jejuni.
Postgraduate Medical Journal
Medicine
Spontaneous Bacterial Peritonitis Due to Actinomyces Mimicking a Perforation of the Proximal Jejunum
American Journal of Case Reports
Medicine
Pregnancy in Adolescence: Is It Really a Concern?
Journal of Evolution of Medical and Dental Sciences
